Sensitivity reflects how reliably a measurable signal identifies affected states, whereas specificity reflects how reliably it distinguishes those states from healthy ones. A candidate with strong diagnostic potential must perform consistently across both dimensions rather than merely change between groups. Evaluating these properties helps determine whether a biomarker can support detection, disease classification, or monitoring without producing misleading results.
Diagnostic signals may arise from molecules, cells, or physiological changes, because disease can alter biology at several levels. Molecular changes may provide one measurable indicator, while cellular or physiological responses offer another view of the affected state. Examining these distinct levels can connect underlying biological mechanisms with measurable findings useful for distinguishing or tracking conditions.
Reproducibility shows whether a candidate signal produces dependable findings when assessment is repeated. A difference observed only once may not support useful interpretation, even if it separates healthy and affected states in an initial study. Reproducible measurements strengthen confidence in a biomarker and are therefore important when validating candidates for eventual clinical use.
Evaluation begins by measuring a candidate feature in relevant samples or through physiological measurements, then determining whether its signal differs reliably between healthy and affected states. Researchers examine sensitivity, specificity, and reproducibility to judge performance. These assessments help establish whether the candidate can contribute to detection, classification, prognosis, or treatment monitoring.
A useful diagnostic signal may support several decisions rather than simple detection alone. Its pattern can help classify disease, provide prognostic information about progression, or indicate changes during treatment monitoring. These applications depend on a reliable difference between biological states and on validation showing that the measurement remains informative for the intended purpose.
Biological research explains how molecular and cellular mechanisms generate measurable signals, while diagnostic development translates those signals into sample-based or physiological assessments. This connection allows researchers to examine candidate biomarkers in biological systems and evaluate their practical value. Successful validation can support tools for research and, ultimately, applications in patient care.